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Background: The compliance of lipid admixtures to physical
emulsion stability parameters is extremely important to ensure
the safety of patients. For example, admixtures containing a per-
centage of fat globules larger than 5 mm in diameter (concept
known as PFAT5) of more than 0.05% might produce toxic effects in
lung and liver. This concern is mainly based on a limited number of
animal studies investigating admixtures with high PFAT5 levels
resulting from 48 h of admixture storage. However, all effects
observed in these studies might as well be attributed to chemical
instability like lipid oxidation, which was not analysed and
therefore could not be excluded.
Aims: This study aims at investigating the correlation of high levels
of PFAT5 in lipid emulsion admixtures with lipid oxidation pa-
rameters under different storage conditions.
Methods: We studied the physical (PFAT5 value) as well as the
chemical (pH, primary and secondary oxidation parameters) sta-
bility of an admixture of a lipid emulsion and an amino acid so-
lution after up to 48 h following different storage conditions
(exposure to oxygen, exposure to artiﬁcial light).Anv, p-anisidine value; AST, aspartate amino transferase; GST, glutathione-S-
dialdehyde; PN, parenteral nutrition; USP, US pharmacopeia.
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M.K. Bothe et al. / Clinical Nutrition Experimental 8 (2016) 25e3326Results: High levels of PFAT5 were only observed after exposure of
the admixture to oxygen. Additional exposure to artiﬁcial light led
to a parallel increase in the primary and secondary oxidation pa-
rameters, while the pH was unchanged.
Conclusions: The admixtures investigated in the former animal
studies were obviously both physically and chemically unstable
and all effects observed in the studies could just as well be caused
by chemical instability, namely the administration of lipid perox-
ides with the admixture.
© 2016 The Authors. Published by Elsevier Ltd on behalf of
European Society for Clinical Nutrition and Metabolism. This is an
open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The stability of lipid emulsions and their admixtures during the infusion period is paramount to the
safety of the patients. Thus, the intravenous infusion of lipid emulsions over a certain period of time
should comply with pharmacopeia speciﬁcations to achieve the potential beneﬁts of the lipid emul-
sions without the adverse effects consequent to physical or chemical instability.
Physical instability occurs when the net negative charge upon the lipid droplets is reduced by the
presence of oppositely charged cations, which are introduced from admixture components such as
electrolytes, minerals or amino acids. The domination of the positive attractive forces over the negative
repulsive forces favours the coalescence of oil droplets. Infusion of fat globules exceeding the internal
diameter of the microvasculature (5 mm) are assumed to induce fat embolism in the lungs, therefore in
lipid emulsions the volume-weighted percentage of fat globules greater than 5 mm, the “PFAT5 level”,
has to be below 0.05% [1]. The US pharmacopeia (USP), however, does not regulate the PFAT5 limit of
admixtures.
The potential toxicity of lipid admixtures with high PFAT5 level has been investigated in several
animal studies [2e5]. One of these studies addressed the toxic effects of a high PFAT5 level on the lung.
In this study, two admixtures of a lipid emulsionwith an amino acid solutionwere used: One prepared
shortly before infusion and one prepared 48 h in advance, leading to the infusion of an “aged”, unstable
solution with a high PFAT5 level. Surprisingly, no microvascular thrombosis was reported in the lungs
after a 24 h infusion of the unstable admixture to guinea pigs [5]. In contrast, these animals showed an
increased cellularity in the lung [5]. This raised the question whether in the respective study a factor
other than PFAT5 was responsible for the unexpected type of lung pathology. Interestingly, malon-
dialdehyde (MDA) was also increased in the lungs of the guinea pigs treated with the unstable
admixture [5]. In general, MDA results from lipid peroxidation of polyunsaturated fatty acids [6]. It can
either arise endogenously during oxidative stress or exogenously from lipid admixtures containing
high levels of polyunsaturated fatty acids in the presence of oxygen and/or ambient light during long-
term storage [7]. Of note, lipid peroxidation end products are not limited toMDA and also include other
aldehydes like 4-hydroxynonenal (4-HNE). Therefore, if MDAwas administered to the guinea pigs, the
even more toxic 4-HNE was administered as well [8]. Administration of 4-HNE induces mitochondrial
dysfunction in human airway epithelial cells in vitro [9] and leads to the accumulation of inﬂammatory
cells in the lung in vivo [10], similar to the observed changes in the guinea pigs [5]. Chemical instability
of the admixture infused to the guinea pig therefore is another potential explanation for the observed
changes, especially as neither protection from light nor protection from oxygen has been reported in
the guinea pig study [5].
We hypothesized that the admixtures infused in the respective animals studies were chemically
unstable despite limited time (48 h) of potential exposure to oxygen and artiﬁcial light. Therefore we
have studied the physical (PFAT5 level) and chemical (pH, primary and secondary oxidation
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20%, and an amino acid solution in different storage conditions and after different ageing times.
2. Materials & methods
2.1. Materials
The admixture analysed in this study is based on the injectable lipid emulsion Intralipid® 20% in
100 mL sterile bottles (batch no. 16HI0261, Fresenius Kabi Austria GmbH, Graz, Austria). The emulsion
was stored at 25 C prior to the experiments. The additional product used for the admixture prepa-
ration was the amino acid solution ProcalAmine® (batch no. J4H018, B. Braun Medical Inc., Irvine, CA,
USA). This amino acid solution was also used in the experiments performed by Driscoll and coworkers
[2e5]. The admixture was prepared by aseptically adding 3 parts of ProcalAmine® and 1 part of
Intralipid® 20% into a sterile glass bottle and gently mixing it before exposing to different ageing
conditions. The composition of the admixture in comparison to the admixture used by Driscoll and
coworkers is given in Table 1.
2.2. Experimental procedure
The admixture was exposed to different ageing conditions and the stability study was performed at
different elapsed times. The different ageing conditions resulted from a combination of protection from
light and exposure to oxygen. Samples protected from light were completely covered with aluminium
foil and stored in a dark place during the study, while samples not protected from light were stored in
transparent bottles in the presence of standard laboratory artiﬁcial light (approximately 500 lx).
Samples exposed to oxygenwere left fully open during the study, while samples protected from oxygen
were sufﬁciently ﬂashed with nitrogen immediately after preparation and tightly sealed. These pro-
cedures resulted in the four different ageing conditions, which are listed in Table 2.
To simulate very aggressive ageing conditions, like rocking transport, a set of samples underwent
stirring at 800 rpm using laboratory magnetic stirrers during the study. This resulted, however, in
obviously visible phase separation of the admixtures after 6 h. Such admixtures could easily be
excluded from patient administration and thus this condition was not further investigated.Table 1
Composition of the 3:1 admixture (solution to emulsion) in comparison to the admixture used by Driscoll and coworkers.
Amount in this study (g/L) Amount in Driscoll et al., 2005 (g/L)
Amino acids 22.0 22.5
Glycerin (from ProcalAmine®) 22.5 22.5
Sodium acetate 1.5 1.5
Magnesium acetate 0.4 0.4
Calcium acetate 0.2 0.2
Sodium chloride 0.9 0.9
Potassium chloride 1.1 1.1
Phosphoric acid NF 0.3 0.3
Potassium metabisulﬁte NF 0.4 0.4
Soybean oil emulsion 50.0 50.0
Water for injection qs qs
Table 2
Different ageing conditions of the 3:1 ProcalAmine®/Intralipid® mixture.
Light exposure Oxygen exposure
Condition 1 (C1) No No
Condition 2 (C2) No Yes
Condition 3 (C3) Yes Yes
Condition 4 (C4) Yes No
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immediately after submitting the samples to the different ageing conditions.
2.3. Analytical procedure
2.3.1. Physical stability
Evolution of PFAT5 of the admixture was studied, at the different storage conditions and different
elapsed times, with an AccuSizer 780, Automatic Particle Sizer APS (Particle Sizing Systems Inc., Santa
Barbara, CA). This equipment claims the use of a Single-Particle Optical Sensor (SPOS) Subsystem
technique implemented by Light Extinction (LE) and/or by Light Scattering (LS) methods, that assumes
to count and to size individual particles as each passes through a thin “optical-sensing zone”. Exper-
imental data from this apparatus and the PFAT5 concept have been questioned as being representative
of emulsion physical stability [11]. It is, however, not the focus of this paper to elaborate on this issue
and as themethod is in accordancewith current USP requirements, the apparatus was considered as an
appropriate method for the purpose of our study. The size range selected for the calculation of PFAT5
was from 5 mm to 50 mm. All measurements were made in triplicate.
2.3.2. Chemical stability
To assess the chemical stability of the admixture, primary and secondary oxidation parameters,
namely Peroxide number (PO) and p-anisidine value (Anv), were determined at the different storage
conditions and elapsed times. These parameters were measured using a built-in spectrophotometer
(FOODLAB fat, CDR s.r.l, Florence, Italy). This device uses CDRs' dedicated test kits for each parameter.
All test kits provided by the CDR are well calibrated in accordance with valid international standards
AOCS (American Oil Chemist Society) controlled by the company Neotron Laboratory (Italy).
Since this device employs pure oil and/or fat in order to determine the oxidation parameters, the oil
part of the admixture had to be extracted from the remaining water phase part. For this purpose, we
used pure ethanol (99.5%) as an extraction agent. Among other oil/fat extraction methods, such as
lyophilization, extraction using ethanol was chosen because of its simplicity, fast extraction time, and
ease of handling.
2.3.3. Statistical analysis
All measurements for the physical parameters were made in triplicate, the ﬁnal value of the
peroxide value was taken from a single measurement, and the ﬁnal value of the p-anisidine value is an
average of duplicate measurements. Due to the limited number of values in this exploratory study, no
statistical analysis was performed.
3. Results
This section will be divided into two parts. The ﬁrst part shows the results regarding the physical
stability for the admixture in the different storage conditions and ageing times. The second part gathers
the results concerning the chemical stabilities.
3.1. Physical stability parameters
Table 3 presents the PFAT5 values of the admixtures for the different storage conditions and elapsed
time studied. The evolution of PFAT5 values is also presented in Fig. 1.
According to the results obtained, the highest PFAT5 values were observed following storage con-
ditions C2 and C3, where samples were exposed to oxygen. For these samples, a small oil layer was
observed at the top of the admixture after 48 h, visually indicating instability. However, it is important
to remark that even for one of these two last conditions (C2), PFAT5 values of the admixture were only
slightly outside the USP speciﬁcation after 24 h elapsed time and that an exponential increase occurred
only after 48 h ageing.
The measurement of PFAT5 for admixtures is complex, as there is high probability of bubble in-
clusions during the admixing, which can be “assigned” as oil droplets and thus contribute to the PFAT5
Table 3
PFAT5 values for the admixture samples studied, as a function of ageing time and storage conditions (n ¼ 3).
PFAT5 (% of fat > 5 mm)
Storage condition Ageing time (h)
0 3 6 24 48
C1
without light/
without oxygen
Mean 0.030 0.008 0.007 0.131 0.914
SD 0.009 0.001 0.001 0.007 0.069
C2
without light/
with oxygen
Mean 0.032 0.039 0.049 0.062 3.180
SD 0.002 0.003 0.002 0.006 0.050
C3
with light/
with oxygen
Mean 0.015 0.023 0.017 0.660 3.710
SD 0.002 0.001 0.005 0.039 0.042
C4
with light/
without oxygen
Mean 0.022 0.038 0.039 0.067 0.250
SD 0.002 0.003 0.004 0.005 0.012
Fig. 1. Evolution of the PFAT5 values of the admixture with ageing time for different storage conditions.
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exposure to light, but no exposure to oxygen) could be considered as excellent.
3.2. Chemical stability parameters
Studies on the oxidative stability of vegetable oils and their admixtures require the measurement of
the evolution of the primary and secondary oxidation products over time. Primary oxidation products
of lipid oxidation are determined by the peroxide value during oil production and storage, and also for
marketing purposes. Secondary oxidation products, such as aldehydes, carbonyls, trienes, and ketones
are determined by the p-anisidine value. Together with the peroxide value, the p-anisidine value can
give relevant information about the oxidation process of the oil [12].
Tables 4 and 5 show the peroxide values and the p-anisidine values, respectively, as a function of
ageing conditions and elapsed time for the admixtures studied. As can be seen in these tables, both
oxidation parameters seem to be affected by the condition “exposure to oxygen” in combination with
“exposure to artiﬁcial light” for ageing times longer than 24 h. This effect is also clearly depicted in
Figs. 2 and 3.
A relevant inﬂuence of the condition “exposure to oxygen” on the p-anisidine values is also
observed when it is combined with the condition “exposure to artiﬁcial light” (see Table 5 and Fig. 3).
Regarding the pH values, there are not signiﬁcant changes during ageing time at any of the storage
conditions studied.
Table 4
Primary oxidation parameter, peroxide values, of the admixtures for different ageing conditions and elapsed time (n ¼ 1).
Peroxide value
Storage condition Ageing time (h)
0 3 6 24 48
C1
without light/without oxygen
mEq O2/L 0.07 0.03 0.03 0.05 0.31
C2
without light/with oxygen
mEq O2/L 0.02 0.02 0.02 0.02 0.85
C3
with light/with oxygen
mEq O2/L 0.02 0.02 0.02 2.00 3.77
C4
with light/without oxygen
mEq O2/L 0.02 0.02 0.02 0.04 0.04
Table 5
Secondary oxidation parameter, p-anisidine values, of the admixtures for different ageing conditions and elapsed time (n ¼ 1).
p-anisidine value
Storage condition Ageing time (h)
0 3 6 24 48
C1
without light/without oxygen
Mean 1.3 0.7 1.1 0.7 1.0
SD 0.1 0.0 0.1 0.0 0.1
C2
without light/with oxygen
Mean 1.0 1.1 1.0 1.0 1.1
SD 0.1 0.2 0.1 0.1 0.1
C3
with light/with oxygen
Mean 1.0 1.1 1.1 1.8 2.4
SD 0.0 0.1 0.1 0.3 0.2
C4
with light/without oxygen
Mean 1.1 0.9 1.0 0.8 0.8
SD 0.1 0.1 0.1 0.1 0.1
Fig. 2. Evolution of the peroxide value of the admixture as a function of ageing time.
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The stability and quality of parenteral nutrition (PN) products like lipid emulsions and their ad-
mixtures during the infusion period is very important for the safety of the patients. Infusion of unstable
lipid emulsions and admixtures may lead to severe side effects, especially in critically ill patients.
Therefore, it is important to make sure that the PN products comply with the pharmacopeia speciﬁ-
cations. According to the USP, lipid injectable emulsions should have a pH between 6 and 9, and the
maximum values of oil mean droplet diameters must be lower than 0.5 mm. In regard to the permitted
percentage of fat globules larger than 5 mm (PFAT5), the USP has limited it to a maximumvalue inferior
Fig. 3. Evolution of the anisidine values of the admixtures as a function of ageing time for the different storage conditions (n ¼ 2).
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quirements [13], as they are intended to be administrated intravenously; however, the USP does not
mention this speciﬁc case [1]. According to this, the current study was performed to determine how
external ageing conditions and elapsed time could affect the ﬁnal quality/stability of the admixture of a
lipid emulsion with an amino acid solution.
Our results clearly show that a remarkable increase in PFAT5 levels within 48 h after preparation
only occurs in the respective admixture after exposure to oxygen. If exposure to oxygen is combined
with exposure to artiﬁcial light, increases in PFAT5 levels coincide with increases in primary and
secondary oxidation parameters and thus increased levels of aldehydes like MDA and 4-HNE. The most
relevant investigations regarding the toxicity of high levels of PFAT5 include three rat studies and one
study in guinea pigs [2e5]. None of these studies reported protection of the samples from light or from
oxygen. It is therefore reasonable to assume that the infused admixtures of those studies both showed
a high PFAT5 as well as a high lipid oxidation level. Here we discuss the results of the former animal
studies in light of this new ﬁnding.
First of all, as mentioned in the introduction, 24 h after infusion of an admixture with a high PFAT5
level, diffuse cellular inﬁltrates as well as increased levels of MDAwere observed in the lung, but not in
the liver of guinea pigs [5]. According to our results, those diffuse cellular inﬁltrates in the lung are
more likely caused by 4-HNE, an end product of lipid oxidation. Our study has the limitation that an
absolute quantiﬁcation of the levels of single lipid oxidation products in the aged admixture is not
feasible due to the indirect measurement in form of the peroxide value, a common stability parameter
of lipid emulsions. Nevertheless, the fact thatMDA is present in both lung and liver of the guinea pigs in
the micromolar level (up to 73 micromol per gram of wet tissue), rather than in the nanomolar level as
observed in other studies of oxidative stress [14], further corroborates the hypothesis that MDA and
other lipid peroxidation products were rather infused than endogenously produced.
In addition to the study in the guinea pig, lipid admixtures with high levels of PFAT5 were also
investigated in several studies in rats [2e4]. The rats showed increased plasma levels of the enzymes
asparagine amino transferase (AST) and glutathione-S-transferase (GST), as well as increased liver
values of MDA after 24 h infusion of an “unstable” admixture [2]. After 72 h infusion, the MDA levels of
the liver were still increased, and same was true for AST in plasma [4]. The changes observed in these
studies were interpreted as hepatotoxic effect, mainly based on increased plasma levels of ASTand GST,
and higher levels of MDA in the liver [4,5].
Of note, AST is a sensitive, but unspeciﬁc liver parameter [15]. The speciﬁc liver parameter alanine
amino transferase (ALT) was not increased in any of the rat studies [2,4]. In humans, an in vivo isolated
elevation of AST is usually due to injury to non-liver cells, mostly muscle cells [16]. Appropriately,
ﬁxation of animals during an experiment leading to aminor extent of muscle injury can cause increases
in AST activity without increases in ALT activity [17]. Of note, the reference values for plasma AST in
Sprague-Dawley rats range from 55.0 to 180.6 U/L with a mean value of 117.8 U/L (http://www.envigo.
com/resources/data-sheets/sprague-dawley-6-8-wk-males-cbc.pdf). The plasma levels measured in
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partially high interindividual variability [2], which might be due to unintentional differences in
handling and ﬁxation. This is further corroborated by the fact that, after 72 h [4] of continuous infusion,
the AST plasma levels of the rats are within the normal range in both treatment groups.
Another plasma parameter of liver injury determined in the rat was the enzyme GST [2]. In general,
GST is responsible for conjugation of substances like lipid peroxides (MDA, 4-HNE) with glutathione to
detoxify them [18]. GST-alpha is a speciﬁc isoenzyme in the liver, and its elevation in plasma is
commonly interpreted as a biomarker for liver injury. In the respective study, total GST and not GST-
alpha was investigated. The increase in plasma GST could therefore be based on increases in GST in
almost all organs or even erythrocytes, which have been shown to possess increased levels of GST
during hyperlipemia similar to that evoked by administration of a high volume of lipids as in the rat
studies [19]. Furthermore, an assumed increase in plasma GST could easily be explained in groups
receiving a high level of lipid peroxides like 4-HNE andMDA as in the “unstable” admixture group [18].
High levels of lipid peroxides lead to high intracellular levels of the detoxifying enzyme GSTand thus in
animals receiving high amounts of lipid peroxides, any single necrotic cell will release more GST than a
cell that does not have to deal with high levels of lipid peroxides.
Asmentioned for the lung of the guinea pigs, the highMDA level in the liver of animals receiving the
“unstable” admixture is most likely due to administration of exogenous MDAwith the lipid admixture.
In summary, none of the reported changes are indicative of liver injury and speciﬁc parameters
indicative of liver injury were either unchanged (ALT) or not investigated (for example GST-alpha,
bilirubin, etc.).
In addition to the parameters of liver injury, parameters of inﬂammation were determined in the
rat. Apart from the fact that administration of lipid peroxides would result in oxidative stress and thus
an inﬂammatory reaction of the body is expected, the selection and evaluation of these parameters has
already been criticized [20] and is not in the focus of this discussion.
In conclusion, none of the three animal studies provides unambiguous evidence for an adverse
effect resulting from high levels of PFAT5 in a lipid admixture. In contrast, an increase in PFAT5 levels
to up to 1% did not change plasma total GST levels signiﬁcantly after 96 h of infusion [3], but merely
led to slight changes in the unspeciﬁc parameter plasma AST (see above). This calls into question the
applicability of the pharmacopeia PFAT5 limit of 0.05% for admixtures. An animal study with
admixtures exclusively consisting of a high PFAT5 or a high lipid oxidation value could substantiate
our results and help to elucidate the actual cause of the observed changes. Nevertheless, our results
show already today that if admixtures with Intralipid® 20% are kept under good storage conditions
without exposure to oxygen, they can be well preserved and considered safe at least until 24 h after
preparation.
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